<DOC>
	<DOCNO>NCT00529178</DOCNO>
	<brief_summary>To determine hypercholesterolemic subject chronic , well-compensated liver disease , percent change baseline Week 12 serum LDL-C pravastatin 80 mg compare placebo .</brief_summary>
	<brief_title>Pravastatin Efficacy Safety Trial Hypercholesterolemic Patients With Chronic Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<criteria>Chronic , wellcompensated stable liver Hypercholesterolemia Signs symptom ascites , jaundice , cirrhosis ChildPugh Score &gt; 5 History disorder affect serum bilirubin level , 1 chronic liver disease , significant endocrine , renal , gastrointestinal disease , uncontrolled hypertension Treatment lipidlowering drug , unless withdrawn within timeframe specify protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>